Replies to post #214359 on Biotech Values

[Whalatane]

IMDZ thx for the detail Dew . Sold my small position at the open
Kiwi

[DewDiligence]

IMDZ CC addendum: The company did not disclose—and no one on the CC asked—whether patients in the placebo arm will be allowed to receive CMB305 after disease progression. I presume that the answer is no.

[Whalatane]

IMDZ...some sell off since your analysis Dew ....now trading at around $6.6

Kiwi

[DewDiligence]

IMDZ selling 18.4M* shares—despite 53% selloff last week!

https://finance.yahoo.com/news/immune-design-announces-proposed-public-201510744.html

The stock is down another 10% in AH trading.

*Assuming exercise of underwriter’s option.